Response of asthmatics on three weeks Intal treatment.
D000328:Adult; D001249:Asthma / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D005082:Physical Exertion; D011241:Prednisone / Q000627:therapeutic use; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D013147:Spirometry; D013997:Time Factors; D014797:Vital Capacity
D002245:Carbon Dioxide; D007545:Isoproterenol; D010100:Oxygen; D011241:Prednisone